SUPN - CIK 0001356576
SUPERNUS PHARMACEUTICALS, INC. has filed 1,154 documents with the SEC between 2006 and 2026. The most frequent type is insider trade (485 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Passive ownership stake | SC 13G | 2024-10-31 | - |
| Passive ownership stake | SC 13G | 2024-02-14 | - |
| Passive ownership stake | SC 13G | 2021-01-25 | - |
| Passive ownership stake | SC 13G | 2020-03-12 | - |
| Passive ownership stake | SC 13G | 2018-02-09 | - |
| Passive ownership stake | SC 13G | 2016-01-28 | - |
| Passive ownership stake | SC 13G | 2014-02-13 | - |
| Passive ownership stake | SC 13G | 2013-12-12 | - |
| Passive ownership stake | SC 13G | 2013-11-04 | - |
| Passive ownership stake | SC 13G | 2013-10-23 | - |
| Passive ownership stake | SC 13G | 2013-05-09 | - |
| Passive ownership stake | SC 13G | 2013-05-06 | - |
| Passive ownership stake | SC 13G | 2012-06-08 | - |